Intraplantar injection of dextrorphan, ketamine or memantine attenuates formalin-induced behaviors

Elyad M. Davidson, Susan M. Carlton

    Research output: Contribution to journalArticle

    120 Citations (Scopus)

    Abstract

    The possible prophylactic effects of local injection of NMDA receptor antagonists that are currently used in humans was investigated in the present study. Intraplantar pretreatment with either 5 mM dextrorphan (DEX), 10 mM memantine (MEM) or 10 mM ketamine (KET) significantly attenuated formalin- induced lifting and licking behaviors, however flinching behavior was not effected. Control experiments indicated that these drug actions could be attributed to local and not systemic effects of the antagonists. We hypothesize that these actions result from blocking NMDA receptors present on unmyelinated sensory axons in the skin. These data suggest that peripheral NMDA receptors contribute to nociceptor activation and can be manipulated to reduce pain of peripheral origin. Since DEX, MEM and KET are currently used in humans and considered clinically safe, they have potential therapeutic value in the treatment of physiologic or pathologic pain states which are induced or maintained by peripheral nociceptor activity. Topical or local application would avoid the side effects that can accompany systemic or intrathecal injection of NMDA antagonists.

    Original languageEnglish
    Pages (from-to)136-142
    Number of pages7
    JournalBrain Research
    Volume785
    Issue number1
    DOIs
    StatePublished - Feb 23 1998

    Fingerprint

    Dextrorphan
    Memantine
    Ketamine
    N-Methyl-D-Aspartate Receptors
    Formaldehyde
    Nociceptors
    Injections
    Pain
    Spinal Injections
    N-Methylaspartate
    Axons
    Skin
    Therapeutics
    Pharmaceutical Preparations

    Keywords

    • Glutamate antagonist
    • NMDA
    • Nociception
    • Spontaneous pain

    ASJC Scopus subject areas

    • Neuroscience(all)

    Cite this

    Intraplantar injection of dextrorphan, ketamine or memantine attenuates formalin-induced behaviors. / Davidson, Elyad M.; Carlton, Susan M.

    In: Brain Research, Vol. 785, No. 1, 23.02.1998, p. 136-142.

    Research output: Contribution to journalArticle

    Davidson, Elyad M. ; Carlton, Susan M. / Intraplantar injection of dextrorphan, ketamine or memantine attenuates formalin-induced behaviors. In: Brain Research. 1998 ; Vol. 785, No. 1. pp. 136-142.
    @article{d87e8b8790484cbeb21e0bd4342660e2,
    title = "Intraplantar injection of dextrorphan, ketamine or memantine attenuates formalin-induced behaviors",
    abstract = "The possible prophylactic effects of local injection of NMDA receptor antagonists that are currently used in humans was investigated in the present study. Intraplantar pretreatment with either 5 mM dextrorphan (DEX), 10 mM memantine (MEM) or 10 mM ketamine (KET) significantly attenuated formalin- induced lifting and licking behaviors, however flinching behavior was not effected. Control experiments indicated that these drug actions could be attributed to local and not systemic effects of the antagonists. We hypothesize that these actions result from blocking NMDA receptors present on unmyelinated sensory axons in the skin. These data suggest that peripheral NMDA receptors contribute to nociceptor activation and can be manipulated to reduce pain of peripheral origin. Since DEX, MEM and KET are currently used in humans and considered clinically safe, they have potential therapeutic value in the treatment of physiologic or pathologic pain states which are induced or maintained by peripheral nociceptor activity. Topical or local application would avoid the side effects that can accompany systemic or intrathecal injection of NMDA antagonists.",
    keywords = "Glutamate antagonist, NMDA, Nociception, Spontaneous pain",
    author = "Davidson, {Elyad M.} and Carlton, {Susan M.}",
    year = "1998",
    month = "2",
    day = "23",
    doi = "10.1016/S0006-8993(97)01396-6",
    language = "English",
    volume = "785",
    pages = "136--142",
    journal = "Brain Research",
    issn = "0006-8993",
    publisher = "Elsevier",
    number = "1",

    }

    TY - JOUR

    T1 - Intraplantar injection of dextrorphan, ketamine or memantine attenuates formalin-induced behaviors

    AU - Davidson, Elyad M.

    AU - Carlton, Susan M.

    PY - 1998/2/23

    Y1 - 1998/2/23

    N2 - The possible prophylactic effects of local injection of NMDA receptor antagonists that are currently used in humans was investigated in the present study. Intraplantar pretreatment with either 5 mM dextrorphan (DEX), 10 mM memantine (MEM) or 10 mM ketamine (KET) significantly attenuated formalin- induced lifting and licking behaviors, however flinching behavior was not effected. Control experiments indicated that these drug actions could be attributed to local and not systemic effects of the antagonists. We hypothesize that these actions result from blocking NMDA receptors present on unmyelinated sensory axons in the skin. These data suggest that peripheral NMDA receptors contribute to nociceptor activation and can be manipulated to reduce pain of peripheral origin. Since DEX, MEM and KET are currently used in humans and considered clinically safe, they have potential therapeutic value in the treatment of physiologic or pathologic pain states which are induced or maintained by peripheral nociceptor activity. Topical or local application would avoid the side effects that can accompany systemic or intrathecal injection of NMDA antagonists.

    AB - The possible prophylactic effects of local injection of NMDA receptor antagonists that are currently used in humans was investigated in the present study. Intraplantar pretreatment with either 5 mM dextrorphan (DEX), 10 mM memantine (MEM) or 10 mM ketamine (KET) significantly attenuated formalin- induced lifting and licking behaviors, however flinching behavior was not effected. Control experiments indicated that these drug actions could be attributed to local and not systemic effects of the antagonists. We hypothesize that these actions result from blocking NMDA receptors present on unmyelinated sensory axons in the skin. These data suggest that peripheral NMDA receptors contribute to nociceptor activation and can be manipulated to reduce pain of peripheral origin. Since DEX, MEM and KET are currently used in humans and considered clinically safe, they have potential therapeutic value in the treatment of physiologic or pathologic pain states which are induced or maintained by peripheral nociceptor activity. Topical or local application would avoid the side effects that can accompany systemic or intrathecal injection of NMDA antagonists.

    KW - Glutamate antagonist

    KW - NMDA

    KW - Nociception

    KW - Spontaneous pain

    UR - http://www.scopus.com/inward/record.url?scp=0032559569&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=0032559569&partnerID=8YFLogxK

    U2 - 10.1016/S0006-8993(97)01396-6

    DO - 10.1016/S0006-8993(97)01396-6

    M3 - Article

    VL - 785

    SP - 136

    EP - 142

    JO - Brain Research

    JF - Brain Research

    SN - 0006-8993

    IS - 1

    ER -